Search Results

Displaying Results 1-1 of 1 "'ACOR'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Flow Sciences Appoints Michael Gesser as Chief Financial Officer

Apr 08, 2026, 08:00 ET Flow Sciences Appoints Michael Gesser as Chief Financial Officer

privately-held companies in the life sciences, pharmaceutical, and medical device sectors. His career includes CFO tenures at Acorda Therapeutics, Inc. (Nasdaq: ACOR), Osmotica Pharmaceutical, Tergus Pharma, BioMedomics, and SunTech Medical. He holds a B.S. from the Cameron School of Business at the University of

More news about: Flow Sciences Inc

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.